Pediatric Praziquantel Consortium

Pediatric Praziquantel Consortium awarded $4.9M from GHIT

Monday, June 1, 2015

The Pediatric Praziquantel Consortium, a consortium dedicated to the development of a new pediatric formulation against schistosomiasis, has received almost $4.9 million from the Japanese Global Health Innovative Technology (GHIT) Fund. The GHIT Fund reaffirms, with this second research grant, its confidence in the work being done by the consortium to offer a treatment solution for pre-school children and the future role that the consortium will be playing for the elimination of schistosomiasis

[Read More]